Current Smoking, Not Duration of Remission, Delays Crohn's Disease Relapse Following Azathioprine Withdrawal

被引：16
|
作者：
Sokol, Harry [1 ]
Seksik, Philippe [1 ]
Nion-Larmurier, Isabelle [1 ]
Vienne, Ariane [1 ]
Beaugerie, Laurent [1 ]
Cosnes, Jacques [1 ]
机构：
[1] Univ Paris 06, St Antoine Hosp, AP HP, Dept Gastroenterol & Nutr, Paris, France
来源：
INFLAMMATORY BOWEL DISEASES | 2010年 / 16卷 / 03期
关键词：
D O I：
10.1002/ibd.20981
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：362 / 363
页数：2
相关论文
共 50 条
  • [21] Crohn's Disease: Changed Body Composition in Remission and Relapse
    Kessing, Richard
    [J]. AKTUELLE ERNAHRUNGSMEDIZIN, 2019, 44 (06): : 377 - 377
  • [22] Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn's Disease
    Wenzl, Heimo H.
    Primas, Christian
    Novacek, Gottfried
    Teml, Alexander
    Oefferlbauer-Ernst, Anna
    Hoegenauer, Christoph
    Vogelsang, Harald
    Petritsch, Wolfgang
    Reinisch, Walter
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (05) : 1414 - 1423
  • [23] Predictors of Relapse Following Withdrawal of Anti-TNF Agents in Patients With Crohn's Disease in Remission - A Systematic Review and Meta-Analysis
    Sofi, Aijaz
    Khan, Sobia
    Alastal, Yaseen
    Rafiq, Ehsan
    Nawras, Ali
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S264 - S264
  • [24] Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn’s Disease
    Heimo H. Wenzl
    Christian Primas
    Gottfried Novacek
    Alexander Teml
    Anna Öfferlbauer-Ernst
    Christoph Högenauer
    Harald Vogelsang
    Wolfgang Petritsch
    Walter Reinisch
    [J]. Digestive Diseases and Sciences, 2015, 60 : 1414 - 1423
  • [25] Efficacy of a second course of azathioprine in patients with Crohn's disease relapsing after azathioprine withdrawal
    Nachury, M
    Lemann, M
    Cosnes, J
    Gornet, JM
    Laurent, B
    Matthieu, A
    Gendre, JP
    Modigliani, R
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A522 - A522
  • [26] Azathioprine and smoking status in Crohn's disease predict response to Infliximab
    Arnott, IDR
    McNeil, G
    Satsangi, J
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A523 - A523
  • [27] Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse
    Marisa Iborra
    Julia Herreras
    Marta Maia Boscá-Watts
    Xavier Cortés
    Galo Trejo
    Elena Cerrillo
    David Hervás
    Miguel Mínguez
    Belén Beltrán
    Pilar Nos
    [J]. Digestive Diseases and Sciences, 2019, 64 : 1612 - 1621
  • [28] Azathioprine and smoking status in Crohn's disease predict response to infliximab
    Arnott, IDR
    Satsangi, J
    [J]. GUT, 2003, 52 : A13 - A13
  • [29] Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse
    Iborra, Marisa
    Herreras, Julia
    Maia Bosca-Watts, Marta
    Cortes, Xavier
    Trejo, Galo
    Cerrillo, Elena
    Hervas, David
    Minguez, Miguel
    Beltran, Belen
    Nos, Pilar
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (06) : 1612 - 1621
  • [30] Smoking, use of oral contraceptives, and medical induction of remission were risk factors for relapse in Crohn's disease
    Logan, RFA
    [J]. GUT, 1999, 44 (03) : 311 - 312
12345